In a ground breaking new development for farmers, and for animal welfare – the Australian Veterinarian Medicine regulator (APVMA) has now extended the approved use of Tri-Solfen® anaesthetic to include the alleviation of pain in lambs, from all breeds, undergoing castration and tail docking.
Already approved and widely used to alleviate pain in lambs undergoing mulesing, Tri-Solfen® has a unique 3-way action designed to numb the wound, minimise bleeding and protect against infection. Scientific trials have demonstrated pain alleviation for up to 24 hours, and improved wound healing.
To date, 60 million lambs have been treated with Tri-Solfen®, with the product available to be purchased, over the counter, from your local veterinarian or rural retailers.
On-going trials conducted by Sydney University Veterinary School, confirmed that Tri-Solfen® is also effective in alleviating pain, post castration and tail docking in lambs. The APVMA has now approved the product for these uses.
“It is a win for farmers, a win for lambs, a win for animal welfare – and a win for the Australian sheep and wool industry”, says Allan Giffard, Managing Director of Animal Ethics. It provides a practical solution for farmers to alleviate the pain associated with these husbandry procedures, all three of which are relied on for important animal health and management reasons. This in turn may improve mothering-up and minimise set-back, whilst also addressing consumer concerns regarding welfare.”
“Farm animals experience pain in the same way as dogs, cats and other companion animals. They deserve the same respect and effort to develop safe, affordable and effective pain relief and wound care, that is practical for farmers to use. Tri-Solfen® is the first product to successfully address this important need.”
It is currently estimated that 70 % of lambs undergoing mulesing each year, receive Tri-Solfen®. Many, or most of these lambs, undergo surgical castration and/or tail docking at the same time. The approval for the extension of use means that Tri-Solfen® may now be used to alleviate pain associated with all 3 wounds, at the same time. It may now also be used on all breeds of sheep. An estimated 20 million sheep are castrated, and 30 million are tail docked, each year.
– Ends –
About Medical Ethics
Medical Ethics is a commercial and development stage company focused on pain mitigation in wounds for humans and animals.
Through our proven patent protected platform technology, we have identified a transformational way of mitigating pain and minimising suffering associated with wounds.
Tri-Solfen® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting Bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.
Allan Giffard, Managing Director
Charles Olsson, Marketing Director
+61 419 362 286
Brett Pollard, Victoria Foster Mitchell
+44 (0)20 3727 1000